BTG PACTUAL PARTICIPATIONS, LTD. ("Company"), pursuant to the provisions of CVM Instruction 358, announces to its shareholders and to the market in general that has signed a transaction involving Brasil Pharma S.A. ("Brasil Pharma"), under the terms described in the material fact hereby attached, also disclosed by Brasil Pharma on this date.
São Paulo, April 6, 2017.
BTG PACTUAL PARTICIPATIONS, LTD.
João Marcello Dantas Leite
Investor Relations Officer
To acess the PDF version, click here.
Investor Relations Department
Phone: +55 (11) 3383-2000
Fax: +55 (11) 3383-2001